Any look ahead at expectations for biotech in 2019 needs to start with a brief recap of the past 12 months because — oh, boy — 2018 was a challenging, healthy, volatile, productive, frustrating, and abundant year. Most of all, it was weird.

A torrent of money poured into the biotech sector but the volume of merger-and-acquisitions dried up and stock prices fell. Initial public offerings set records but average returns were mediocre. The Food and Drug Administration approved more drugs in a single calendar year than ever before, but squabbles over pricing and reimbursement grew more intense. Commercial launches were hit or miss. The pace of scientific breakthroughs quickened but optimism was often overshadowed by macro fears about tariffs and looming trade wars.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Any word on Methadone use for pain management. There’s serious talk in NY State that it will be banned for pain use in 2019. I’m as 51-yr old Chronic Intractable Pain patient since 2003.
    Without my high dose Methadone (150mg twice a day), I’m as good as DEAD! Yet you’d never know I was on any drug, it just lowers my pain enough to keep my from ending it all. I also have Degenerative Disc Disease and Fibromyalgia. My father served at Camp Lejeune from 1952-55 and died of Kidney Failure (a class action suit) and it’s now know children of these men develop Neuromuscular/autoimmune diseases. No other meds work on me due to Hyperthymusism (part of my Advanced General Myasthenia Gravis).
    I get answers NOWHERE, my pain doctor has become totally paranoid by the DEA’s “War On Opioids”???
    I voluntarily went to a psych every week for 8-years (2004-2012 until NY cut my Straight Medicaid off thanks to Obamacare) to watch for any signs of addiction, which were NEVER seen. I’ve refused more opioids than I’ve ever taken because I KNOW they don’t work! Then doctors look at me like I’m crazy??? All I want is my pain at a level I can live with and still help people for free, which is what I’ve done my entire life.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy